These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2540961)
61. Analysis of progesterone receptor binding in the ovine uterus. Bauer MA; Gorell TA Steroids; 1980 Nov; 36(5):581-91. PubMed ID: 7192894 [TBL] [Abstract][Full Text] [Related]
62. Quantification of progesterone binding in mammary tissue of pregnant ewes. Smith JJ; Capuco AV; Akers RM J Dairy Sci; 1987 Jun; 70(6):1178-85. PubMed ID: 3611473 [TBL] [Abstract][Full Text] [Related]
63. Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus promoter. Aurrekoetxea-Hernández K; Buetti E J Virol; 2000 Jun; 74(11):4988-98. PubMed ID: 10799572 [TBL] [Abstract][Full Text] [Related]
64. Protein-DNA interactions at steroid hormone regulated genes. Scheidereit C; von der Ahe D; Cato AC; Wenz M; Suske G; Carlson C; Bosshard H; Westphal HM; Beato M Endocr Res; 1989; 15(4):417-40. PubMed ID: 2561356 [TBL] [Abstract][Full Text] [Related]
65. Overexpression of a partial human androgen receptor in E. coli: characterization of steroid binding, DNA binding, and immunological properties. Young CY; Qiu SD; Prescott JL; Tindall DJ Mol Endocrinol; 1990 Dec; 4(12):1841-9. PubMed ID: 2127955 [TBL] [Abstract][Full Text] [Related]
66. Affinity of interactions between human glucocorticoid receptors and DNA: at physiologic ionic strength, stable binding occurs only with DNAs containing partially symmetric glucocorticoid response elements. Tully DB; Cidlowski JA Biochemistry; 1990 Jul; 29(28):6662-70. PubMed ID: 2168738 [TBL] [Abstract][Full Text] [Related]
67. A model for hormone receptor binding to the mouse mammary tumour virus regulatory element based on hydroxyl radical footprinting. Chalepakis G; Postma JP; Beato M Nucleic Acids Res; 1988 Nov; 16(21):10237-47. PubMed ID: 2848219 [TBL] [Abstract][Full Text] [Related]
68. Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity. Robin-Jagerschmidt C; Wurtz JM; Guillot B; Gofflo D; Benhamou B; Vergezac A; Ossart C; Moras D; Philibert D Mol Endocrinol; 2000 Jul; 14(7):1028-37. PubMed ID: 10894152 [TBL] [Abstract][Full Text] [Related]
69. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. Sartorius CA; Tung L; Takimoto GS; Horwitz KB J Biol Chem; 1993 May; 268(13):9262-6. PubMed ID: 8387487 [TBL] [Abstract][Full Text] [Related]
70. Hormonal induction of transfected genes depends on DNA topology. Piña B; Haché RJ; Arnemann J; Chalepakis G; Slater EP; Beato M Mol Cell Biol; 1990 Feb; 10(2):625-33. PubMed ID: 2153920 [TBL] [Abstract][Full Text] [Related]
71. The use of a DNA-binding domain replacement method for the detection of a potential TR3 orphan receptor response element in the mouse mammary tumor virus long terminal repeat. Lee HJ; Kokontis J; Wang KC; Chang C Biochem Biophys Res Commun; 1993 Jul; 194(1):97-103. PubMed ID: 8392847 [TBL] [Abstract][Full Text] [Related]
72. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation. Gass EK; Leonhardt SA; Nordeen SK; Edwards DP Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977 [TBL] [Abstract][Full Text] [Related]
73. Estrogen-insensitive progesterone receptors in a human breast cancer cell line: characterization of receptors and of a ligand exchange assay. Mockus MB; Lessey BA; Bower MA; Horwitz KB Endocrinology; 1982 May; 110(5):1564-71. PubMed ID: 7200421 [TBL] [Abstract][Full Text] [Related]
74. The leucine zippers of c-fos and c-jun for progesterone receptor dimerization: A-dominance in the A/B heterodimer. Mohamed MK; Tung L; Takimoto GS; Horwitz KB J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):241-50. PubMed ID: 7826885 [TBL] [Abstract][Full Text] [Related]
75. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins. Terakawa N; Shimizu I; Tanizawa O; Matsumoto K J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133 [TBL] [Abstract][Full Text] [Related]
76. A bacterially expressed mineralocorticoid receptor is associated in vitro with the 90-kilodalton heat shock protein and shows typical hormone- and DNA-binding characteristics. Caamaño CA; Morano MI; Patel PD; Watson SJ; Akil H Biochemistry; 1993 Aug; 32(33):8589-95. PubMed ID: 8395210 [TBL] [Abstract][Full Text] [Related]
77. Characterization of transiently and constitutively expressed progesterone receptors: evidence for two functional states. Smith CL; Wolford RG; O'Neill TB; Hager GL Mol Endocrinol; 2000 Jul; 14(7):956-71. PubMed ID: 10894147 [TBL] [Abstract][Full Text] [Related]
78. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Nardulli AM; Katzenellenbogen BS Endocrinology; 1988 Apr; 122(4):1532-40. PubMed ID: 3345726 [TBL] [Abstract][Full Text] [Related]
79. Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter. Archer TK; Lee HL; Cordingley MG; Mymryk JS; Fragoso G; Berard DS; Hager GL Mol Endocrinol; 1994 May; 8(5):568-76. PubMed ID: 8058066 [TBL] [Abstract][Full Text] [Related]
80. Occurrence of common binding sites for progestin and glucocorticoid in the lactating mammary gland of the rat. Maki M; Hirose M; Chiba H J Biochem; 1980 Dec; 88(6):1845-54. PubMed ID: 7193205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]